» Articles » PMID: 34531478

Modelling COVID-19 Severity in the Republic of Ireland Using Patient Co-morbidities, Socioeconomic Profile and Geographic Location, February to November 2020

Overview
Journal Sci Rep
Specialty Science
Date 2021 Sep 17
PMID 34531478
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding patient progression from symptomatic COVID-19 infection to a severe outcome represents an important tool for improved diagnoses, surveillance, and triage. A series of models have been developed and validated to elucidate hospitalization, admission to an intensive care unit (ICU) and mortality in patients from the Republic of Ireland. This retrospective cohort study of patients with laboratory-confirmed symptomatic COVID-19 infection included data extracted from national COVID-19 surveillance forms (i.e., age, gender, underlying health conditions, occupation) and geographically-referenced potential predictors (i.e., urban/rural classification, socio-economic profile). Generalised linear models and recursive partitioning and regression trees were used to elucidate COVID-19 progression. The incidence of symptomatic infection over the study-period was 0.96% (n = 47,265), of whom 3781 (8%) required hospitalisation, 615 (1.3%) were admitted to ICU and 1326 (2.8%) died. Models demonstrated an increasingly efficacious fit for predicting hospitalization [AUC 0.816 (95% CI 0.809, 0.822)], admission to ICU [AUC 0.885 (95% CI 0.88 0.89)] and death [AUC of 0.955 (95% CI 0.951 0.959)]. Severe obesity (BMI ≥ 40) was identified as a risk factor across all prognostic models; severely obese patients were substantially more likely to receive ICU treatment [OR 19.630] or die [OR 10.802]. Rural living was associated with an increased risk of hospitalization (OR 1.200 (95% CI 1.143-1.261)]. Urban living was associated with ICU admission [OR 1.533 (95% CI 1.606-1.682)]. Models provide approaches for predicting COVID-19 prognoses, allowing for evidence-based decision-making pertaining to targeted non-pharmaceutical interventions, risk-based vaccination priorities and improved patient triage.

Citing Articles

COVID-19 preparedness and response in rural and remote areas: A scoping review.

Dudley L, Couper I, Kannangarage N, Naidoo S, Ribas C, Koller T PLOS Glob Public Health. 2023; 3(11):e0002602.

PMID: 37967067 PMC: 10651055. DOI: 10.1371/journal.pgph.0002602.


Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.

Candel F, Barreiro P, Salavert M, Cabello A, Fernandez-Ruiz M, Perez-Segura P Viruses. 2023; 15(7).

PMID: 37515137 PMC: 10383267. DOI: 10.3390/v15071449.


Identifying Novel Data-Driven Dietary Patterns via Dimensionality Reduction and Associations with Socioeconomic Profile and Health Outcomes in Ireland.

Burke D, Bennett A, Hynds P, Priyadarshini A Nutrients. 2023; 15(14).

PMID: 37513674 PMC: 10385811. DOI: 10.3390/nu15143256.


Spatio-temporal evolution of COVID-19 in the Republic of Ireland and the Greater Dublin Area (March to November 2020): A space-time cluster frequency approach.

Boudou M, Khandelwal S, OhAiseadha C, Garvey P, ODwyer J, Hynds P Spat Spatiotemporal Epidemiol. 2023; 45:100565.

PMID: 37301603 PMC: 9840564. DOI: 10.1016/j.sste.2023.100565.


Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.

OhAiseadha C, Quinn G, Connolly R, Wilson A, Connolly M, Soon W Int J Environ Res Public Health. 2023; 20(7).

PMID: 37047846 PMC: 10094123. DOI: 10.3390/ijerph20075223.


References
1.
Domegan L, Garvey P, McKeown P, Johnson H, Hynds P, ODwyer J . Geocoding cryptosporidiosis cases in Ireland (2008-2017)-development of a reliable, reproducible, multiphase geocoding methodology. Ir J Med Sci. 2021; 190(4):1497-1507. PMC: 7813664. DOI: 10.1007/s11845-020-02468-0. View

2.
Kwok S, Adam S, Ho J, Iqbal Z, Turkington P, Razvi S . Obesity: A critical risk factor in the COVID-19 pandemic. Clin Obes. 2020; 10(6):e12403. PMC: 7460880. DOI: 10.1111/cob.12403. View

3.
Melgert B, Oriss T, Qi Z, Dixon-McCarthy B, Geerlings M, Hylkema M . Macrophages: regulators of sex differences in asthma?. Am J Respir Cell Mol Biol. 2009; 42(5):595-603. PMC: 2874445. DOI: 10.1165/rcmb.2009-0016OC. View

4.
Klein S . Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bioessays. 2012; 34(12):1050-9. PMC: 4120666. DOI: 10.1002/bies.201200099. View

5.
von dem Knesebeck O, Verde P, Dragano N . Education and health in 22 European countries. Soc Sci Med. 2006; 63(5):1344-51. DOI: 10.1016/j.socscimed.2006.03.043. View